bioMérieux (BIM.PA) Financial Analysis & Valuation | Quarter Chart
bioMérieux (BIM.PA)
BIM.PAPrice: $79.09
Fair Value: 🔒
🔒score
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, a... more
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious ... more
Description
Shares
| Market Cap | $9.33B | Exchange | PAR |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | FR | CEO | Pierre Boulud |
| IPO Date | 2004-07-07 | CAGR | 0.07% |
| Employees | 14,147 | Website | www.biomerieux.com |
| Div. Yield | 1.4% | Payout Ratio | 0.27% |
| Buy Back Yield | 0.74% | Total Yield | 2.14% |
BIM.PA chart loading...
Fundamentals
Technicals
| Enterprise Value | $12.34B | P/E Ratio | 20.6 |
| Forward P/E | 14.42 | PEG Ratio | 2.23 |
| P/S Ratio | 1.86 | P/B Ratio | 1.84 |
| P/CF Ratio | 9.59 | P/FCF Ratio | 16.73 |
| EPS | $3.84 | EPS Growth 1Y | 2.2% |
| EPS Growth 3Y | 56.15% | EPS Growth 5Y | 237.2% |
| Revenue Growth 1Y | 10.82% | Gross Margin | 0.53% |
| Operating Margin | 0.1% | Profit Margin | 0.1% |
| ROE | 0.1% | ROA | 0.07% |
| ROCE | 0.09% | Current Ratio | 2.39 |
| Quick Ratio | 1.48 | Cash Ratio | 0.54 |
| Debt/Equity | 0.11 | Interest Coverage | 51.77 |
| Altman Z Score | 5.72 | Piotroski Score | 7 |